利记·sbobet(中国)-唯一官方网站

2014-12-04

The “Fosun•Chinese Association of Plastics and Aesthetics Science Technology Award” is Set up to Promote the Sci-Tech Progress in

(29 November 2014-China)At the Beijing press conference on November 29, Chinese Association of Plastics and Aesthetics announced the establishment of “Chinese Association of Plastics and Aesthetics Science Technology Award”, the highest award in China’s medical plastic surgery industry. The award is entitled “Fosun•Chinese Association of Plastics and Aesthetics Science Technology Award” by Fosun Pharma, which has made a special subject donation of RMB700, 000 to support the first session award through Fosun Public Welfare Foundation. Present at the press conference were Zhang Bin, Director of Chinese Association of Plastics and Aesthetics, Zhao Zhenmin, Secretary General of Chinese Association of Plastics and Aesthetics, Ma Changzheng, Chairman of the Board of Fosun Pharma’s medical equipment business division, along with industry experts and over 10 media.

It’s said that the award is intended to promote scientific and technological progress and innovation in China’s medical plastic surgery industry, establish a “Chinese-style” medical plastic surgery technology brand, and commend groups and individuals for their significant contributions to the fundamental research, application research, scientific & technological invention and international scientific and technological cooperation of medical plastic surgery. Awards include 1 invention award, 3 innovation awards, 6 progress awards, 1 international cooperation award and a lifetime achievement award. The award application is expected to officially kick off next year.

Every year, tens of thousands of Chinese reportedly have plastic surgeries in Korea in the name of medical travel, converging into what is called a “Korean plastic surgery” fever. “Korean-style” plastic surgery is featured, yet China’s medical plastic surgery service level is definitely not lower than overseas and is somewhat more advanced. As the number of China’s monthly surgeries even exceeds a year’s worth in neighboring countries, China’s medical plastic surgeons are exposed to more practices, and therefore are able to accumulate more clinical experience and achieve more proficient clinical skills, which in turn help promote medical service quality and talent training and development. At present, China’s medical plastic surgery service level has basically reached an international advanced level, with some of these services even being internationally leading. China has become the world’s second largest plastic surgery country, next to the U.S., fully capable of meeting medical plastic surgery demands at different levels.

Speaking at the press conference, Ma Changzheng, Chairman of the Board of Fosun Pharma’s medical equipment business division, commented, Fosun Pharma expects to help promote China’s plastic surgery technology and service level as well as the healthy development of China’s plastic surgery industry by donating to “Fosun Chinese Association of Plastics and Aesthetics Science Technology Award”. Sanguine about the development of China’s medical plastic surgery industry, Fosun Pharma will continue to develop medical plastic surgery services in virtue of its resources advantages in the field. In addition, Fosun Pharma expects further strong support and help from Chinese Association of Plastics and Aesthetics and experts, to facilitate the rapid growth in China’s medical plastic surgery service business.


 Has long been preserving the principle of sustainable development, Fosun Pharma is committed to the development of public welfare cause. Since 1998, Fosun Pharma has participated at and organized a wealth of public welfare activities across various countries and regions, in such areas as education and research, environmental research, medical care, social need and culture. Currently, Fosun Pharma has already built a well-established public welfare mechanism, i.e. “future star” public welfare program, a CSR program designed to promote public welfare by supporting education, aiding scientific and technological research, pharmaceutical and health community service, offering medical care to sickened orphans, making donations to the poor, and disaster relief aid.